NCT05576805View on ClinicalTrials.gov

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

CompletedOBSERVATIONAL
Enrollment

159

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Cytomegalovirus (CMV)
Trial Locations (15)

3000

UZ Leuven, Leuven

6020

MU Innsbruck, Innsbruck

8036

MU Graz, Graz

21100

U Insubria, Varese

43126

U Parma, Parma

49100

Rabin Medical Center, Petah Tikva

V5Z 1M9

Vancouver GH (VCH), Vancouver

541 24

Aristotle USM, Thessaloniki

00133

FP Vergata, Roma

3015 GD

Erasmus UMC, Rotterdam

3584 CX

UMC Utrech, Utrecht

80-952

UCC Gdansk, Gdansk

02-097

MU Warsaw, Warsaw

171 64

Karolinska UH, Solna

751 85

Uppsala UH, Uppsala

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT05576805 - A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada | Biotech Hunter | Biotech Hunter